|
gptkbp:instanceOf
|
gptkb:peripherally_acting_mu-opioid_receptor_antagonist
gptkb:drug
gptkb:opioid
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
2014
|
|
gptkbp:ATCCode
|
A06AH04
|
|
gptkbp:brand
|
gptkb:Movantik
Moventig
|
|
gptkbp:CASNumber
|
99532-79-9
|
|
gptkbp:category
|
gptkb:laxative
opioid withdrawal agent
|
|
gptkbp:contraindication
|
known or suspected gastrointestinal obstruction
|
|
gptkbp:developer
|
gptkb:AstraZeneca
|
|
gptkbp:eliminationHalfLife
|
6-11 hours
|
|
gptkbp:hasMolecularFormula
|
C34H51NO11
|
|
gptkbp:hasSMILES
|
CC(C)OC(=O)[C@@H]1CC[C@H]2[C@@]3(CCN4CCC[C@]34O2)[C@H]1O[C@H]5CO[C@H](CO)[C@@H](O)[C@H]5O
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
blocks peripheral mu-opioid receptors
|
|
gptkbp:metabolism
|
gptkb:CYP3A4
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
23667555
28536141
CHEMBL2105752
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
vomiting
diarrhea
abdominal pain
flatulence
|
|
gptkbp:UNII
|
6V9V1KG1LU
|
|
gptkbp:usedFor
|
opioid-induced constipation
|
|
gptkbp:bfsParent
|
gptkb:Movantik
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
naloxegol
|